A Swiss multicentre phase II study of capecitabine plus oxaliplatin (CAPOX) in combination with preoperative pelvic radiotherapy in patients (pts) with locally advanced rectal cancer

被引：0
|
作者：
Koeberle, D. [1 ]
Burkhard, R. [2 ]
Von Moos, R. [3 ]
Winterhalder, R. [4 ]
Hess, V. [5 ]
Heitzmann, F. [6 ]
Ruhstaller, T. [1 ]
Terraciano, L. [7 ]
Bieri, G. [5 ]
Toepfer, M. [1 ]
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] Stadtspital Triemli, Zurich, Switzerland
[3] Kantonsspital Graubunden, Chur, Switzerland
[4] Kantonsspital Luzern, Luzern, Switzerland
[5] Universitatspital Basel, Basel, Switzerland
[6] Stadtspital Waid, Zurich, Switzerland
[7] Universitatsspital Basel, Basel, Switzerland
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70957-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3029
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
    Koeberle, D.
    Burkhard, R.
    von Moos, R.
    Winterhalder, R.
    Hess, V.
    Heitzmann, F.
    Ruhstaller, T.
    Terraciano, L.
    Neuweiler, J.
    Bieri, G.
    Rust, C.
    Toepfer, M.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (07) : 1204 - 1209
  • [2] Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
    D Koeberle
    R Burkhard
    R von Moos
    R Winterhalder
    V Hess
    F Heitzmann
    T Ruhstaller
    L Terraciano
    J Neuweiler
    G Bieri
    C Rust
    M Toepfer
    [J]. British Journal of Cancer, 2008, 98 : 1204 - 1209
  • [3] Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
    Norifumi Hattori
    Goro Nakayama
    Keisuke Uehara
    Toshisada Aiba
    Kiyoshi Ishigure
    Eiji Sakamoto
    Yuichiro Tojima
    Mitsuro Kanda
    Daisuke Kobayashi
    Chie Tanaka
    Suguru Yamada
    Masahiko Koike
    Michitaka Fujiwara
    Masato Nagino
    Yasuhiro Kodera
    [J]. International Journal of Clinical Oncology, 2020, 25 : 118 - 125
  • [4] Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
    Hattori, Norifumi
    Nakayama, Goro
    Uehara, Keisuke
    Aiba, Toshisada
    Ishigure, Kiyoshi
    Sakamoto, Eiji
    Tojima, Yuichiro
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Yamada, Suguru
    Koike, Masahiko
    Fujiwara, Michitaka
    Nagino, Masato
    Kodera, Yasuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) : 118 - 125
  • [5] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Junichi Nishimura
    Junichi Hasegawa
    Takeshi Kato
    Shinichi Yoshioka
    Shingo Noura
    Yoshinori Kagawa
    Masayoshi Yasui
    Masakazu Ikenaga
    Kohei Murata
    Taishi Hata
    Chu Matsuda
    Tsunekazu Mizushima
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 82 : 707 - 716
  • [7] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Kato, Takeshi
    Yoshioka, Shinichi
    Noura, Shingo
    Kagawa, Yoshinori
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Murata, Kohei
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 707 - 716
  • [8] Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) or capecitabine alone (CAP) in patients (PTS) with locally advanced rectal cancer (LARC).
    Marrodan, Ines
    Rubio, Itziar
    Buque, Aitziber
    Sancho, Aintzane
    Fuente, Natalia
    Carrera, Sergio
    Arruti, Mikel
    Manel Mane, Joan
    Isabel Gutierrez, Eddy
    Iruarrizaga, Eluska
    Azkona, Eider
    Lopez-Vivanco, Guillermo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Phase II clinical trial of weekly oxaliplatin concurrent with capecitabine plus preoperative radiotherapy in locally advanced resectable rectal cancer
    Majem, M.
    Navarro, M.
    Losa, F.
    Alonso, V.
    Gallen, M.
    Benavides, M.
    Rivera, F.
    Escudero, P.
    Massuti, B.
    Aranda, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
12345